A microarray study to characterize the molecular mechanism of TIMP-3-mediated tumor rejection
Open Access
- 31 July 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (1) , 144-152
- https://doi.org/10.1016/j.ymthe.2005.02.028
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer developmentBritish Journal of Cancer, 2003
- Metalloproteinase inhibitors: biological actions and therapeutic opportunitiesJournal of Cell Science, 2002
- Regulation of membrane type-matrix metalloproteinasesSeminars in Cancer Biology, 2002
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- Matrix metalloproteinases: a tail of a frog that became a princeNature Reviews Molecular Cell Biology, 2002
- Tissue inhibitors of metalloproteinases: evolution, structure and functionBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Matrix metalloproteinases and their biological function in human gliomasInternational Journal of Developmental Neuroscience, 1999
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasisThe FASEB Journal, 1993
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993